Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antineoplastic Agents, Phytogenic | 3 | 2016 | 622 | 0.510 |
Why?
|
| Benzofurans | 1 | 2014 | 142 | 0.490 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2014 | 193 | 0.470 |
Why?
|
| Luteolin | 1 | 2012 | 12 | 0.440 |
Why?
|
| Surface Plasmon Resonance | 4 | 2014 | 271 | 0.270 |
Why?
|
| Cell Proliferation | 4 | 2016 | 10477 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2015 | 3574 | 0.170 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 134 | 0.140 |
Why?
|
| Triterpenes | 1 | 2016 | 72 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5457 | 0.140 |
Why?
|
| Deoxycytidine | 2 | 2016 | 818 | 0.130 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 190 | 0.120 |
Why?
|
| Cyclophilin A | 2 | 2011 | 58 | 0.120 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2012 | 461 | 0.120 |
Why?
|
| Sugar Alcohol Dehydrogenases | 1 | 2013 | 14 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13576 | 0.120 |
Why?
|
| Gynostemma | 1 | 2012 | 1 | 0.120 |
Why?
|
| Sapogenins | 1 | 2012 | 2 | 0.120 |
Why?
|
| Catechin | 1 | 2013 | 70 | 0.110 |
Why?
|
| Cell Survival | 2 | 2014 | 5914 | 0.110 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2016 | 639 | 0.110 |
Why?
|
| Aromatase Inhibitors | 1 | 2016 | 493 | 0.110 |
Why?
|
| Molecular Structure | 2 | 2014 | 1899 | 0.110 |
Why?
|
| NADP | 1 | 2013 | 228 | 0.110 |
Why?
|
| Cadherins | 1 | 2016 | 911 | 0.100 |
Why?
|
| Mice, Nude | 2 | 2015 | 3713 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 387 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2014 | 5236 | 0.100 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 16630 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 5094 | 0.080 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 934 | 0.080 |
Why?
|
| Antigens, Ly | 1 | 2009 | 294 | 0.080 |
Why?
|
| Serine | 1 | 2012 | 822 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2012 | 3165 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2015 | 8487 | 0.070 |
Why?
|
| Radiometry | 1 | 2012 | 800 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 1907 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2014 | 2980 | 0.070 |
Why?
|
| Flavonoids | 1 | 2009 | 449 | 0.070 |
Why?
|
| Multigene Family | 1 | 2009 | 1116 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2013 | 6669 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2011 | 1204 | 0.070 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2015 | 1536 | 0.070 |
Why?
|
| Histones | 2 | 2012 | 2559 | 0.060 |
Why?
|
| Neoplasms | 1 | 2012 | 20941 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2011 | 1028 | 0.060 |
Why?
|
| Apoptosis | 2 | 2016 | 9756 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 10971 | 0.050 |
Why?
|
| Protein Binding | 2 | 2012 | 9469 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3822 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2015 | 5171 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4172 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7494 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8452 | 0.040 |
Why?
|
| Peptides | 1 | 2010 | 4390 | 0.040 |
Why?
|
| Ribonucleosides | 1 | 2015 | 81 | 0.030 |
Why?
|
| Proteins | 1 | 2010 | 6088 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2015 | 296 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 10884 | 0.030 |
Why?
|
| Hydrogen Bonding | 1 | 2013 | 292 | 0.030 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2012 | 106 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2093 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 2406 | 0.020 |
Why?
|
| Humans | 12 | 2016 | 725187 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 29672 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 940 | 0.020 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2010 | 38 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2013 | 696 | 0.020 |
Why?
|
| Vincristine | 1 | 2012 | 1050 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2011 | 5460 | 0.020 |
Why?
|
| Animals | 4 | 2015 | 168714 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1372 | 0.020 |
Why?
|
| Time Factors | 1 | 2012 | 40186 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 119 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 927 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20448 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 557 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 3024 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 433 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 319 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 2012 | 578 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2009 | 460 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 1187 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2692 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 976 | 0.020 |
Why?
|
| Introns | 1 | 2009 | 994 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 4350 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3137 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 4896 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2272 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 10251 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 4388 | 0.010 |
Why?
|
| Protein Transport | 1 | 2009 | 2015 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2429 | 0.010 |
Why?
|
| Ligands | 1 | 2010 | 3282 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1821 | 0.010 |
Why?
|
| Virus Replication | 1 | 2011 | 2546 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3902 | 0.010 |
Why?
|
| Binding Sites | 1 | 2011 | 6133 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2013 | 4278 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7819 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2947 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4875 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 12991 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 11968 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13932 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 18301 | 0.010 |
Why?
|
| Genome, Human | 1 | 2009 | 4430 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9669 | 0.010 |
Why?
|
| Female | 3 | 2016 | 375449 | 0.010 |
Why?
|
| HIV-1 | 1 | 2011 | 6849 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9379 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 212292 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 57656 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 61761 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 80300 | 0.010 |
Why?
|
| Male | 2 | 2016 | 347096 | 0.010 |
Why?
|
| HIV Infections | 1 | 2011 | 16202 | 0.000 |
Why?
|
| Aged | 1 | 2016 | 161486 | 0.000 |
Why?
|
| Adult | 1 | 2016 | 211615 | 0.000 |
Why?
|
Concepts
(121)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_